clorotepine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| tricyclic compounds | 3912 | 13448-22-1 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
major tranquilizer with action similar to those of the phenothiazines; used in schizophrenic & manic psychoses; minor decriptor (77-86); on-line & INDEX MEDICUS search DIBENZOTHIEPINS (77-86); RN given refers to parent cpd without isomeric designation
|
Drug dosage:
None
ADMET properties:
None
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
None
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 8.35 | Basic |
| pKa2 | 1.0 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| D(2) dopamine receptor | GPCR | Ki | 9.17 | CHEMBL | |||||
| 5-hydroxytryptamine receptor 2C | GPCR | Ki | 9.24 | CHEMBL | |||||
| 5-hydroxytryptamine receptor 6 | GPCR | Ki | 8.67 | PDSP | |||||
| D(3) dopamine receptor | GPCR | Ki | 9.37 | PDSP | |||||
| Histamine H1 receptor | GPCR | Ki | 9.72 | CHEMBL | |||||
| D(4) dopamine receptor | GPCR | Ki | 9.40 | PDSP | |||||
| Trace amine-associated receptor 1 | GPCR | Ki | 6.31 | PDSP | |||||
| Potassium channel subfamily K member 9 | Ion channel | IC50 | 4.13 | CHEMBL | |||||
| Alpha-1D adrenergic receptor | GPCR | Ki | 9.11 | CHEMBL | |||||
| D(2) dopamine receptor | GPCR | Ki | 9.30 | CHEMBL | |||||
| 5-hydroxytryptamine receptor 2A | GPCR | Ki | 9.64 | CHEMBL | |||||
| D(1A) dopamine receptor | GPCR | Ki | 8.64 | CHEMBL | |||||
| Alpha-1A adrenergic receptor | GPCR | Ki | 9.18 | CHEMBL | |||||
| D(3) dopamine receptor | GPCR | Ki | 8.62 | CHEMBL | |||||
| Alpha-1B adrenergic receptor | GPCR | Ki | 9.25 | CHEMBL | |||||
| Dopamine receptor | GPCR | IC50 | 8.52 | CHEMBL | |||||
| Adrenergic receptor alpha-1 | GPCR | IC50 | 9.74 | CHEMBL | |||||
| Serotonin 2 (5-HT2) receptor | GPCR | IC50 | 9.24 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| C0069353 | UMLSCUI |
| CHEBI:135459 | CHEBI |
| CHEMBL64249 | ChEMBL_ID |
| DB15971 | DRUGBANK_ID |
| C100288 | MESH_SUPPLEMENTAL_RECORD_UI |
| 1238 | PUBCHEM_CID |
| 3423 | INN_ID |
| E65W20MU7A | UNII |
Pharmaceutical products:
None